Shengbao Yan
Overview
Explore the profile of Shengbao Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Zeng Q, Tang Y, Yan S, Li Y, Gao S, et al.
ORL J Otorhinolaryngol Relat Spec
. 2021 Sep;
83(6):428-433.
PMID: 34510035
Background: Sublingual immunotherapy (SLIT) had good effectiveness for children with allergic rhinitis (AR). However, no studies explored the effect of persistent allergen exposure on SLIT treatment. Coronavirus disease 2019 (COVID-19)...
2.
Liu W, Zeng Q, Yan S, Sun C, Tang Y, Luo R
Int Arch Allergy Immunol
. 2020 Sep;
181(12):934-940.
PMID: 32937623
A good compliance often attributes to good efficacy and safety of sublingual immunotherapy (SLIT). However, few studies have been conducted on the safety of SLIT treatment in children. We aimed...
3.
Liu W, Zeng Q, He C, Chen R, Tang Y, Yan S, et al.
Pediatr Allergy Immunol
. 2020 Aug;
32(1):86-91.
PMID: 32810884
Background: Although previous studies had confirmed the effectiveness and safety of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), respectively, direct head-to-head comparison of SCIT vs SLIT is sparse. We aimed...
4.
Luo X, Zeng Q, Yan S, Liu W, Luo R
World Allergy Organ J
. 2020 Aug;
13(8):100451.
PMID: 32802247
Background: Studies have shown that the number and function of type II innate lymphoid cells (ILC2) in peripheral blood of allergic rhinitis (AR) children increased significantly. This study aims to...
5.
Liu W, Zeng Q, Wen Y, Tang Y, Yan S, Li Y, et al.
Ann Allergy Asthma Immunol
. 2020 Aug;
126(2):152-161.e1.
PMID: 32771356
Background: Interleukin (IL)-35 and IL-35-producing regulatory T cells (iTr35) have been reported to inhibit T2 response in allergic rhinitis (AR). However, its effects on type II innate lymphoid cells (ILC2)...